Scientific platform

mRNA Immune Service

mRNA design system

LNP delivery system

Antigen AI prediction system

GMP process development

mRNA Immune Service

mRNA Immune Service

Chengshi Biomedical Technology focuses on the R&D of innovative biopharmaceutical technologies, with core businesses including the development of mRNA vaccines for veterinary use and the development of customized mRNA-LNP formulations. Leveraging advanced technology and extensive experience, the company's research team is dedicated to providing efficient and safe biopharmaceutical products and services to meet the ever-changing market demands and requirements.

Service Types:

  • Service Introduction:Veterinary mRNA Vaccine Development: Veterinary vaccines are crucial for preventing and controlling animal diseases. Chengshi Biomedical Technology utilizes its comprehensive mRNA vaccine development system, coupled with a high-level R&D team, to focus on the development of mRNA vaccines for veterinary use. The company's veterinary mRNA vaccines demonstrate significant advantages in protective efficacy and long-term immune effects, offering a new solution for animal disease prevention.
  • Customized mRNA-LNP Formulation:Chengshi Biomedical Technology offers customized mRNA-LNP formulation services based on advanced mRNA technology. This service is particularly suitable for antibody discovery and preparation, significantly enhancing the efficiency and success rate of antibody R&D through optimized target sequences and efficient expression techniques.

Service Highlights:

  • Veterinary mRNA Vaccines: The mRNA vaccines for veterinary use developed by Chengshi Biomedical Technology not only effectively stimulate humoral and cellular immune responses but also offer high safety and cost-effectiveness. They provide rapid and broad-spectrum immune protection, effectively controlling the spread of animal diseases and strongly supporting the healthy development of the livestock industry.
  • Customized mRNA-LNP Formulations: Based on its powerful mRNA vaccine development platform, Chengshi Biomedical Technology can offer customized protein expression solutions to clients. By combining different expression architectures and optimizing the expression of target proteins, the company significantly improves the positive clone rate. It has successfully assisted multiple clients in antibody discovery for various targets, providing solid technical support for drug development and immunological research. For inquiries, please contact us through the inquiry system below.

Phone: 025-58860997

Address: 2nd Floor, Building A-4, Building 16, Shuwu, No. 73 Tanmi Road, Jiangbei New Area, Nanjing

Mailbox: info@therarna.cn

Copyright©2023 Nanjing Chengshi Biopharmaceutical Technology Co., Ltd Filing number:苏ICP备2024060502